scispace - formally typeset
M

Meng Zhou

Researcher at University of Miami

Publications -  74
Citations -  6400

Meng Zhou is an academic researcher from University of Miami. The author has contributed to research in topics: Nanoclusters & Excited state. The author has an hindex of 30, co-authored 71 publications receiving 4457 citations. Previous affiliations of Meng Zhou include Chinese Academy of Sciences & Northeast Normal University.

Papers
More filters
Journal ArticleDOI

Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities

TL;DR: This review summarizes the major progress in the field, including the principles that permit atomically precise synthesis, new types of atomic structures, and unique physical and chemical properties ofatomically precise nanoparticles, as well as exciting opportunities for nanochemists to understand very fundamental science of colloidal nanoparticles.
Journal ArticleDOI

H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.

TL;DR: It is shown that natural H-ferritin (HFn) nanocages can carry high doses of doxorubicin (Dox) for tumor-specific targeting and killing without any targeting ligand functionalization or property modulation, which makes the HFn nanocage an ideal vehicle for efficient anticancer drug delivery.
Journal ArticleDOI

Manipulating aggregation and molecular orientation in all-polymer photovoltaic cells.

TL;DR: By replacing the polymeric donor PBDTBDD with its 2D-conjugated polymer PBDD-T, the power conversion efficiency of OPVs featuring the anisotropic polymer acceptor PNDI is drastically boosted from 2.4% up to 5.8%.
Journal ArticleDOI

Crystal structure of a luminescent thiolated Ag nanocluster with an octahedral Ag64+ core

TL;DR: A yellow luminescent thiolate-protected Ag(14)(SC(6)H(3)F(2))(12)(PPh(3))(8) cluster was synthesized and structurally characterized by single-crystal X-ray analysis.
Journal ArticleDOI

Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma.

TL;DR: H-ferritin (HFn) nanocarrier both successfully crosses the blood brain barrier and kills glioma tumor cells, and possesses the potential to serve as a therapeutic approach against a broad range of central nervous system diseases.